ID   SYNJ2_RAT               Reviewed;        1496 AA.
AC   O55207; Q91ZD8; Q91ZD9;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 2.
DT   02-OCT-2024, entry version 170.
DE   RecName: Full=Synaptojanin-2;
DE            EC=3.1.3.36 {ECO:0000250|UniProtKB:Q9D2G5};
DE   AltName: Full=Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2;
GN   Name=Synj2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2A), AND CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=9388224; DOI=10.1074/jbc.272.49.30817;
RA   Nemoto Y., Arribas M., Haffner C., de Camilli P.;
RT   "Synaptojanin 2, a novel synaptojanin isoform with a distinct targeting
RT   domain and expression pattern.";
RL   J. Biol. Chem. 272:30817-30821(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2B1 AND 2B2), SUBCELLULAR LOCATION,
RP   AND MUTAGENESIS OF ASP-388; GLY-435 AND ARG-466.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11498538; DOI=10.1074/jbc.m106404200;
RA   Nemoto Y., Wenk M.R., Watanabe M., Daniell L., Murakami T., Ringstad N.,
RA   Yamada H., Takei K., De Camilli P.;
RT   "Identification and characterization of a synaptojanin 2 splice isoform
RT   predominantly expressed in nerve terminals.";
RL   J. Biol. Chem. 276:41133-41142(2001).
RN   [3]
RP   INTERACTION WITH SYNJ2BP, SUBCELLULAR LOCATION (ISOFORM 2A), AND
RP   MUTAGENESIS.
RX   PubMed=10357812; DOI=10.1093/emboj/18.11.2991;
RA   Nemoto Y., De Camilli P.;
RT   "Recruitment of an alternatively spliced form of synaptojanin 2 to
RT   mitochondria by the interaction with the PDZ domain of a mitochondrial
RT   outer membrane protein.";
RL   EMBO J. 18:2991-3006(1999).
CC   -!- FUNCTION: Inositol 5-phosphatase which may be involved in distinct
CC       membrane trafficking and signal transduction pathways. May mediate the
CC       inhibitory effect of Rac1 on endocytosis (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol 4-phosphate) + phosphate; Xref=Rhea:RHEA:22764,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58178,
CC         ChEBI:CHEBI:58456; EC=3.1.3.36;
CC         Evidence={ECO:0000250|UniProtKB:Q9D2G5};
CC   -!- SUBUNIT: Binds to GRB2 (By similarity). Isoform 2A binds to
CC       SYNJ2BP/OMP25. {ECO:0000250, ECO:0000269|PubMed:10357812}.
CC   -!- INTERACTION:
CC       O55207-3; Q9WVJ4: Synj2bp; NbExp=9; IntAct=EBI-7007476, EBI-7007454;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11498538}. Cell
CC       membrane {ECO:0000269|PubMed:11498538}. Presynapse
CC       {ECO:0000269|PubMed:11498538}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:11498538}. Membrane raft. Note=Localizes at
CC       presynapse terminals in brain and at bundles of microtubules
CC       surrounding the nucleus in the elongating spermatids corresponding to
CC       the manchette (PubMed:11498538). Translocates from the cytoplasm to
CC       membrane ruffles in a RAC1-dependent manner (PubMed:11498538).
CC       {ECO:0000269|PubMed:11498538}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2A]: Mitochondrion
CC       {ECO:0000269|PubMed:10357812}. Note=Interaction of isoform 2A with
CC       SYNJ2BP/OMP25 results in localization to the mitochondrion
CC       (PubMed:10357812). {ECO:0000269|PubMed:10357812}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist. Experimental confirmation
CC         may be lacking for some isoforms.;
CC       Name=2B2;
CC         IsoId=O55207-1; Sequence=Displayed;
CC       Name=2B1;
CC         IsoId=O55207-2; Sequence=VSP_012914;
CC       Name=2A; Synonyms=7.5kb;
CC         IsoId=O55207-3; Sequence=VSP_012915, VSP_012916;
CC       Name=7.2kb;
CC         IsoId=O55207-4; Sequence=Not described;
CC       Name=6.0kb;
CC         IsoId=O55207-5; Sequence=Not described;
CC       Name=5.2kb;
CC         IsoId=O55207-6; Sequence=Not described;
CC       Name=3.5kb;
CC         IsoId=O55207-7; Sequence=Not described;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoforms 2B1 and 2B2 are
CC       concentrated at nerve terminals in brain and at spermatid manchette in
CC       testis.
CC   -!- MISCELLANEOUS: [Isoform 2A]: The PDZ domain of isoform 2A binds
CC       SYNJ2BP/OMP25. Mutagenesis of Ser-1246 or Val-1248 to Ala abolishes
CC       SYNJ2BP/OMP25 binding. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the synaptojanin family. {ECO:0000305}.
CC   -!- SIMILARITY: In the central section; belongs to the inositol 1,4,5-
CC       trisphosphate 5-phosphatase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U90312; AAB92481.1; -; mRNA.
DR   EMBL; AY034050; AAK61722.1; -; mRNA.
DR   EMBL; AY034051; AAK61723.1; -; mRNA.
DR   RefSeq; NP_001106842.1; NM_001113371.1.
DR   RefSeq; NP_001106843.1; NM_001113372.1.
DR   RefSeq; NP_114460.1; NM_032071.2.
DR   AlphaFoldDB; O55207; -.
DR   SMR; O55207; -.
DR   ELM; O55207; -.
DR   IntAct; O55207; 1.
DR   MINT; O55207; -.
DR   STRING; 10116.ENSRNOP00000059744; -.
DR   iPTMnet; O55207; -.
DR   PhosphoSitePlus; O55207; -.
DR   PaxDb; 10116-ENSRNOP00000062564; -.
DR   GeneID; 84018; -.
DR   KEGG; rno:84018; -.
DR   AGR; RGD:69436; -.
DR   CTD; 8871; -.
DR   RGD; 69436; Synj2.
DR   eggNOG; KOG0566; Eukaryota.
DR   InParanoid; O55207; -.
DR   OrthoDB; 21647at2759; -.
DR   PhylomeDB; O55207; -.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:O55207; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0032587; C:ruffle membrane; IDA:RGD.
DR   GO; GO:0052659; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; IDA:RGD.
DR   GO; GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; IDA:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0052744; F:phosphatidylinositol monophosphate phosphatase activity; IDA:RGD.
DR   GO; GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0017124; F:SH3 domain binding; IPI:RGD.
DR   GO; GO:0071545; P:inositol phosphate catabolic process; IDA:RGD.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISO:RGD.
DR   CDD; cd12720; RRM_SYNJ2; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   Gene3D; 3.60.10.10; Endonuclease/exonuclease/phosphatase; 1.
DR   InterPro; IPR036691; Endo/exonu/phosph_ase_sf.
DR   InterPro; IPR046985; IP5.
DR   InterPro; IPR000300; IPPc.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR002013; SAC_dom.
DR   InterPro; IPR015047; SYNJ1/2_RRM.
DR   InterPro; IPR034973; SYNJ2_RRM.
DR   PANTHER; PTHR11200; INOSITOL 5-PHOSPHATASE; 1.
DR   PANTHER; PTHR11200:SF148; SYNAPTOJANIN-2; 1.
DR   Pfam; PF08952; DUF1866; 1.
DR   Pfam; PF22669; Exo_endo_phos2; 1.
DR   Pfam; PF02383; Syja_N; 1.
DR   SMART; SM01165; DUF1866; 1.
DR   SMART; SM00128; IPPc; 1.
DR   SUPFAM; SSF56219; DNase I-like; 1.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS50275; SAC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Cytoplasm;
KW   Cytoskeleton; Hydrolase; Lipid metabolism; Membrane; Mitochondrion;
KW   Phosphoprotein; Reference proteome; RNA-binding; Synapse.
FT   CHAIN           1..1496
FT                   /note="Synaptojanin-2"
FT                   /id="PRO_0000209735"
FT   DOMAIN          120..444
FT                   /note="SAC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00183"
FT   DOMAIN          906..985
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          450..?
FT                   /note="Catalytic"
FT                   /evidence="ECO:0000250"
FT   REGION          1047..1083
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1100..1149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1205..1357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1393..1413
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1442..1461
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1468..1496
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1052..1072
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1113..1130
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1265..1279
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1281..1295
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15056"
FT   VAR_SEQ         1085..1129
FT                   /note="Missing (in isoform 2B1)"
FT                   /evidence="ECO:0000303|PubMed:11498538"
FT                   /id="VSP_012914"
FT   VAR_SEQ         1254..1293
FT                   /note="PMLPEEQCEQQPVHFTMASQEMNLETPPPITAPIPPVPKP -> IVFCSSSQ
FT                   ASQPCSLLQRHEFVRTVAAQRLTPVDASGSSV (in isoform 2A)"
FT                   /evidence="ECO:0000303|PubMed:9388224"
FT                   /id="VSP_012915"
FT   VAR_SEQ         1294..1496
FT                   /note="Missing (in isoform 2A)"
FT                   /evidence="ECO:0000303|PubMed:9388224"
FT                   /id="VSP_012916"
FT   MUTAGEN         388
FT                   /note="D->N: Abolishes phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:11498538"
FT   MUTAGEN         435
FT                   /note="G->V: Reduced phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:11498538"
FT   MUTAGEN         466
FT                   /note="R->H: No effect."
FT                   /evidence="ECO:0000269|PubMed:11498538"
FT   CONFLICT        1130
FT                   /note="T -> A (in Ref. 2; AAK61722)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1496 AA;  165264 MW;  CB15017BF7821648 CRC64;
     MALSKGLRLL ARLDPTGPSS VLLEARGRGD CLLFEAGAVA TLAPEEKEVI KGLYGKPTDA
     YGCLGELSLK SGGVPLSFLV LVTGCTSVGR IPDAEIYKIT GTEFYPLQEE AKEEDRLPAL
     KKILSSGVFY FAWPNDGACF DLTIRAQKQG DDCSEWGTSF FWNQLLHVPL RQHQVNCHDW
     LLKVICGVVT IRTVYASHKQ AKACLISRIS CERAGARFLT RGVNDDGHVS NFVETEQAIY
     MDDGVSSFVQ IRGSVPLFWE QPGLQVGSHH LRLHRGLEAN APAFERHMVL LKEQYGQQVV
     VNLLGSRGGE EVLNRAFKKL LWASCHAGDT PMINFDFHQF AKGRKLEKLE NLLRPQLKLH
     WDDFGVFAKG ENVSPRFQKG TLRMNCLDCL DRTNTVQCFI ALEVLHLQLE SLGLNSKPIT
     DRFVESFKAM WSLNGHGLSK VFTGSRALEG KAKVGKLKDG ARSMSRTIQS NFFDGVKQEA
     IKLLLVGDVY NEESTDKGRM LLDNTALLGL GSNKQNSLSG MLDGKATPRI LKAMTERQSE
     FTNFKRIQIA MGTWNVNGGK QFRSNLLGTT ELTDWLLDAP QLSGAVDSQD DGGPADIFAV
     GFEEMVELSA GNIVNASTTN RKMWGEQLQK AISRSHRYIL LTSAQLVGVC LYIFVRPYHV
     PFIRDVAIDT VKTGMGGKAG NKGAVGIRFQ FHSTSFCFIC SHLTAGQSQV KERNEDYREI
     THKLSFPSGR NIFSHDYVFW CGDFNYRIDL TYEEVFYFVK RQDWKKLMEF DQLQLQKSSG
     KIFKDFHEGT INFGPTYKYD VGSAAYDTSD KCRTPAWTDR VLWWRKKHPY DKTAGELNLL
     DSDLDGDANI RHTWSPGTLK YYGRAELQAS DHRPVLAIVE VEVQEVDVGA RERVFQEVSS
     VQGPLDATVI VNLQSPTLEE RNEFPEDLRT ELMQTLGNYG TIILVRINQG QMLVTFADSH
     SALSVLDVDG MKVKGRAVKI RPKTKDWLEG LREELIRKRD SMAPVSPTAN SCLLEENFDF
     TSLDYESEGD VLEDDEDYLA DEFGQPVVSD SELGGDDSSD TMSASTPASK SPALAKKKQH
     PTYKDDADLM TLKLELEVAG NFRHRSPSRS LSVPNRPRPP HPPQRPPPPT GLMVKKSASD
     ASISSGTHGQ YSILQTAKLL PGAPQQPPKA RTGISKPYNV KQIKTTNAQE AEAAIRCLLE
     AGGGVPESAP GATPLRNQGS SKPEASLGPP VLPRRPVPRV PTMKKPTLRR TGKPMLPEEQ
     CEQQPVHFTM ASQEMNLETP PPITAPIPPV PKPRTFQPGR GVERRPSGGK PEPDDAPPVT
     GAVELSSPEA PEAPSLAPKV PPRRKKSAPA AFHLQVLQSN SQLLQGLTCS SSSPSPPKPD
     TPLLYPQMAL GTSSAISPET DGPRVTEPEA ASFHGDYPDP FWSLLHHPKL LNNNTWLSKS
     SEPLDLGSRT PERTHTDSAQ VNASVVERGL PPDHGGKDFS HWMAASNKDK RTTLGV
//
